MC
BMY icon

Miramar Capital’s Bristol-Myers Squibb BMY Stock Holding History

Miramar Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13M Sell
214,738
-5,005
-2% -$292K 2.9% 19
2025
Q4 		$11.9M Buy
219,743
+1,518
+0.7% +$73K 2.59% 22
2025
Q3 		$9.84M Sell
218,225
-1,196
-0.5% -$55.9K 2.18% 25
2025
Q2 		$10.2M Buy
219,421
+5,302
+2% +$260K 2.4% 24
2025
Q1 		$13.1M Buy
214,119
+35,858
+20% +$2.09M 3.11% 14
2024
Q4 		$10.1M Buy
178,261
+169,385
+1,908% +$9.46M 2.4% 22
2024
Q3 		$459K Hold
8,876
– – 0.11% 46
2024
Q2 		$369K Buy
8,876
+2,600
+41% +$116K 0.09% 50
2024
Q1 		$276K Hold
6,276
– – 0.07% 51
2023
Q4 		$322K Sell
6,276
-1,900
-23% -$99.7K 0.08% 48
2023
Q3 		$475K Sell
8,176
-1,794
-18% -$110K 0.13% 44
2023
Q2 		$638K Sell
9,970
-1,103
-10% -$74K 0.16% 40
2023
Q1 		$767K Hold
11,073
– – 0.2% 40
2022
Q4 		$797K Sell
11,073
-200
-2% -$15.1K 0.21% 46
2022
Q3 		$899K Sell
11,273
-518
-4% -$37.6K 0.25% 44
2022
Q2 		$908K Buy
11,791
+334
+3% +$25.4K 0.26% 42
2022
Q1 		$837K Buy
+11,457
New +$769K 0.23% 54
2020
Q1 		– Sell
-4,239
Closed -$273K – 44
2019
Q4 		$273K Buy
+4,239
New +$243K 0.17% 46

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Miramar Capital's BMY Position: Q1 2026 in Review

Miramar Capital reduced its Bristol-Myers Squibb (BMY) stake by 2.3% in Q1 2026, selling an estimated $292K and leaving 214,738 shares worth $13M. The position accounts for 2.9% of the portfolio, ranked #19.

Miramar Capital first reported a position in BMY in Q4 2019 and has held it in 18 quarters since. The position peaked at $13.1M in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Miramar Capital held 214,738 shares of Bristol-Myers Squibb worth $13M as of Q1 2026.
  • Miramar Capital sold 5,005 Bristol-Myers Squibb shares in Q1 2026, an estimated $292K.
  • Bristol-Myers Squibb made up 2.9% of Miramar Capital's portfolio in Q1 2026, its #19 holding.
  • Miramar Capital first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 18 quarters since.
  • Miramar Capital's Bristol-Myers Squibb position peaked at $13.1M in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Miramar Capital's 13F filing for Q1 2026, filed 11 May 2026.